Drug Trial Radar · NCT02559895
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
Last checked: Nov 20, 2026Latest source record: May 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
898
Actual
Start
Sep 2015
Primary completion
Feb 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- Alder Biopharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 25, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess ALD403 in the prevention of migraine headache in frequent episodic migraineurs.
Conditions
- Migraine Disorders
Interventions
ALD403Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Monthly Migraine Days (Weeks 1-12)Time frame: Week 1-12
Locations
87 sites in 2 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Phoenix, Arizona
Research Site
Tucson, Arizona
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Fresno, California
Research Site
Fullerton, California
Research Site
Long Beach, California
Research Site
Montclair, California
Research Site
Oceanside, California
Research Site
Redlands, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
Santa Monica, California
Research Site
Sherman Oaks, California
Research Site
Colorado Springs, Colorado
Research Site
Fort Collins, Colorado
Research Site
Stamford, Connecticut
Research Site
Waterbury, Connecticut
Research Site
Bradenton, Florida
Research Site
DeLand, Florida
Research site
Fort Myers, Florida
Research Site
Hallandale, Florida
Research Site
Hialeah, Florida
Research Site
Maitland, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Naples, Florida
Research Site
Orlando, Florida
Research Site
Sunrise, Florida
Research Site
Winter Haven, Florida
Research Site
Atlanta, Georgia
Research Site
Atlanta, Georgia
Research Site
Stockbridge, Georgia
Research Site
Chicago, Illinois
Research Site
Lisle, Illinois
Research Site
Prairie Village, Kansas
Research Site
Lexington, Kentucky
Research Site
Owensboro, Kentucky
Showing 40 of 87 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.